cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Clearside Biomedical Inc
1 own
9 watching
Current Price
$1.48
$0.01
(0.68%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
89.08M
52-Week High
52-Week High
2.85
52-Week Low
52-Week Low
0.98
Average Volume
Average Volume
0.32M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization89.08M
icon52-Week High2.85
icon52-Week Low0.98
iconAverage Volume0.32M
iconDividend Yield--
iconP/E Ratio--
What does the Clearside Biomedical Inc do?
Clearside Biomedical, Inc., a biopharmaceutical company, focuses on the revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space. The company offers XIPERE, a triamcinolone acetonide suprachoroidal injectable suspension for the treatment of uveitis macular edema. It also develops CLS-AX, an axitinib injectable suspension for suprachoroidal injection, which is in Phase 1/2a clinical trial; and CLS-301, an integrin inhibitor suspension for the treatment of diabetic macular edema and macular degeneration. The company has a collaboration with Bausch Health, Arctic Vision, REGENXBIO, Inc., and Aura Biosciences. Clearside Biomedical, Inc. was incorporated in 2011 and is headquartered in Alpharetta, Georgia.
Read More
How much money does Clearside Biomedical Inc make?
News & Events about Clearside Biomedical Inc.
Globe Newswire
2days ago
ALPHARETTA, Ga., Feb. 06, 2023 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc.(NASDAQ:CLSD), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space (SCS), today announced that its Chief Medical Officer and Chief Development ...
Benzinga
6days ago
Clearside Biomedical Inc(NASDAQ: CLSD) announced results from the Extension Study of its OASIS Phase 1/2a trial of CLS-AX (axitinib) administered by suprachoroidal injection via SCS Microinjector in neovascular age-related macular degeneration participants. read more...
PR Newswire
2 months ago
Thinking about buying stock in Macy's, Immunic, LexinFintech, Provention Bio, or Clearside Biomedical? Thinking about buying stock in Macy's, Immunic, LexinFintech, Provention Bio, or Clearside Biomedical? PR Newswire NEW YORK, Nov. 17, 2022 NEW YORK, Nov. 17, 2022 /PRNewswire...
Benzinga
3 months ago
Latest Ratings for CLSD DateFirmActionFromTo Mar 2022JMP SecuritiesMaintainsMarket Outperform Jul 2021HC Wainwright & Co.Initiates Coverage OnBuy Jun 2021WedbushMaintainsOutperform View More Analyst Ratings for CLSD View the Latest Analyst Ratings read more...
Frequently Asked Questions
Frequently Asked Questions
What is Clearside Biomedical Inc share price today?
plus_minus_icon
Can Indians buy Clearside Biomedical Inc shares?
plus_minus_icon
How can I buy Clearside Biomedical Inc shares from India?
plus_minus_icon
Can Fractional shares of Clearside Biomedical Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Clearside Biomedical Inc stocks?
plus_minus_icon
What is today’s traded volume of Clearside Biomedical Inc?
plus_minus_icon
What is today’s market capitalisation of Clearside Biomedical Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Clearside Biomedical Inc?
plus_minus_icon
What percentage is Clearside Biomedical Inc down from its 52-Week High?
plus_minus_icon
What percentage is Clearside Biomedical Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$1.48
$0.01
(0.68%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00